UK markets open in 7 hours 13 minutes

Inogen, Inc. (INGN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
41.74+0.04 (+0.10%)
At close: 4:00PM EDT
42.15 +0.41 (+0.98%)
After hours: 05:58PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close41.70
Open41.87
Bid41.77 x 800
Ask42.20 x 800
Day's range41.45 - 42.12
52-week range26.90 - 82.35
Volume83,462
Avg. volume196,424
Market cap943.779M
Beta (5Y monthly)1.03
PE ratio (TTM)N/A
EPS (TTM)-0.11
Earnings date04 Nov 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est71.00
  • Business Wire

    Inogen to Announce Third Quarter 2021 Financial Results on November 4, 2021

    GOLETA, Calif., October 13, 2021--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release third quarter 2021 financial results after market close on Thursday, November 4, 2021. The Company will host a corresponding conference call beginning at 2:00pm PT/5:00pm ET.

  • Business Wire

    Inogen Appoints Stanislav Glezer as Chief Technology Officer

    GOLETA, Calif., October 12, 2021--Inogen, Inc. (NASDAQ: INGN), ("Inogen" or "the Company"), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that Stanislav Glezer, MD has been appointed to the role of Chief Technology Officer responsible for R&D and Engineering, Medical Affairs, and Regulatory Affairs. Mr. Glezer will remain an Executive Vice President of the Company.

  • Zacks

    Here's Why You Should Retain Inogen (INGN) Stock For Now

    Investors continue to be optimistic about Inogen (INGN) on its potential in the POC space and a strong product portfolio.